- ICH GCP
- US Clinical Trials Registry
- Researchers
- Korea, Republic of
- Clear Cell Renal Cell Carcinoma
Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Clear Cell Renal Cell Carcinoma
Total 28 results
-
Chang Gon Kim, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Choong-kun Lee, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Dae-Ho Lee, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Gun Min Kim, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Han Sang Kim, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Hyun Moo Lee, M.D.,Ph.D.Seen in:
- Seoul, Samsung Medical Center
Trials:- NCT01069770 (Principal Investigator)
Conditions: -
Hyun-Ae Jung, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Hyung-Don Kim, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Jae-Ho Jeong, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Jeong-Eun Kim, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Ji-Yun Lee, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Jin-Seok Ahn, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Jong-Mu Sun, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Min Hee Hong, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Min Hwan Kim, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
SANG JOON SHIN, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Sang-We Kim, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Se-Hoon Lee, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Se-Young Seo, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Seh-Hoon Park, MD, PhDSeen in:
- Seoul, Samsung Seoul Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Seung-Hoon Beom, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04903873 (Sub-Investigator)
-
Shin-Kyo Yoon, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Sun Young Rha, MDSeen in:
- Seoul, Severance Hospital
Trials:- NCT04374877 (Principal Investigator)
-
Tae-Yong Kim, MDSeen in:
- Seoul, Seoul National University Hospital
- Seoul, Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center
Trials:- NCT04374877 (Principal Investigator)
- NCT05359861 (Principal Investigator)
-
Tak Yun, MD, PhDSeen in:
- Ilsan, National Cancer Center
Trials:- NCT04903873 (Sub-Investigator)
-
Won-Young Choi, MD, PhDSeen in:
- Ilsan, National Cancer Center
Trials:- NCT04903873 (Sub-Investigator)
-
Yong-Sang Hong, MD, PhDSeen in:
- Seoul, Seoul Asan
Trials:- NCT04903873 (Sub-Investigator)
-
Yoon-Koo Kang, MDSeen in:
- Seoul, Asan Medical Center
Trials:- NCT04374877 (Principal Investigator)
Clinical Trials on Clear Cell Renal Cell Carcinoma
-
Celldex TherapeuticsTerminatedKidney Neoplasms | Metastatic Renal Cell Carcinoma | Ovarian Clear Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma (RCC) | Clear-cell Renal Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Guru SonpavdePfizer; Hoosier Cancer Research NetworkWithdrawnKidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney CarcinomaUnited States
-
Osel, Inc.National Cancer Institute (NCI); City of Hope Medical Center; Miyarisan Pharmaceuticals...RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
Peloton Therapeutics, Inc.Active, not recruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Kidney Cancer | Clear Cell Renal Cell Carcinoma | Glioblastoma | Solid Tumor | Glioblastoma Multiforme | Advanced Solid Tumors | GBM | Solid Tumor, Adult | Solid Carcinoma | Glioblastoma, Adult | ccRCC | RCC, Clear Cell Adenocarcinoma | RCC | Renal Cell Carcinoma, Metastatic | Renal Cell Carcinoma Recurrent | Renal Cell...
-
Association Pour La Recherche des Thérapeutiques...CompletedClear-cell Metastatic Renal Cell Carcinoma | Clear-cell Renal CarcinomaFrance
-
Queen Mary University of LondonAstraZeneca; Vall d'Hebron Institute of OncologyActive, not recruitingRenal Clear Cell Carcinoma | Renal Papillary Cell CarcinomaUnited Kingdom
-
AmgenCompletedRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Clear Cell Renal Carcinoma | Renal Cell AdenocarcinomaFrance, United States, Germany
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8United States